Gatifloxacin can affect blood glucose more than other quinolones.
Package inserts for all of the quinolones list high and low blood sugar as possible side effects in diabetic patients. These problems seem more likely with gatifloxacin than other quinolones.
The FDA reports 477 cases of blood sugar problems in 10 million prescriptions for gatifloxacin. This is more than all the blood sugar problems for ciprofloxacin, levofloxacin, and moxifloxacin combined.
The use of gatifloxacin is now contraindicated in Japan in patients with diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote